The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR-NRI) Concept in Analgesia: The Case of Tapentadol.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 319, doi. 10.1007/s40263-014-0151-9
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2014 AND VI 28 AND IP 4
Results: 8
1
2
Role of Lithium Augmentation in the Management of Major Depressive Disorder.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 331, doi. 10.1007/s40263-014-0152-8
- By:
- Publication type:
- Article
3
Psychopharmacological Treatment of Neurocognitive Deficits in People with Schizophrenia: A Review of Old and New Targets.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 301, doi. 10.1007/s40263-014-0146-6
- By:
- Publication type:
- Article
4
Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 343, doi. 10.1007/s40263-014-0149-3
- By:
- Publication type:
- Article
5
Assessment of the Abuse Liability of a Dual Orexin Receptor Antagonist: A Crossover Study of Almorexant and Zolpidem in Recreational Drug Users.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 361, doi. 10.1007/s40263-014-0150-x
- By:
- Publication type:
- Article
6
Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 373, doi. 10.1007/s40263-014-0155-5
- By:
- Publication type:
- Article
7
The Evidence for a Beneficial Role of Vitamin A in Multiple Sclerosis.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 291, doi. 10.1007/s40263-014-0148-4
- By:
- Publication type:
- Article
8
Recent Advances in the Pharmacotherapy of Infantile Spasms.
- Published in:
- CNS Drugs, 2014, v. 28, n. 4, p. 279, doi. 10.1007/s40263-014-0139-5
- By:
- Publication type:
- Article